Looking for Sucralose pharmaceutical excipients? Find information on Sucralose's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Sansweet su 100, Aspasvit, Sucrazit
Sucralose is a disaccharide derivative consisting of 4-chloro-4-deoxy-alpha-D-galactopyranose and 1,6-dichloro-1,6-dideoxy-beta-D-fructofuranose units linked by a glycosidic bond. It has a role as an environmental contaminant, a xenobiotic and a sweetening agent. It is a disaccharide derivative and an organochlorine compound.

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDA Dossiers

read-more
read-more

01

Dosage Form : GUM, CHEWING

SUCRALOSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : GUM, CHEWING

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : BUCCAL

CAS : 56038132

UNII : 96K6UQ3ZD4

Potency Amount : 3.5

Potency Unit : MG

blank

02

Dosage Form : SPRAY

SUCRALOSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SPRAY

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : NASAL

CAS : 56038132

UNII : 96K6UQ3ZD4

Potency Amount : 0.15

Potency Unit : %

blank

03

Dosage Form : SPRAY, METERED

SUCRALOSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SPRAY, METERED

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : NASAL

CAS : 56038132

UNII : 96K6UQ3ZD4

Potency Amount : 0.15

Potency Unit : %

blank

04

Dosage Form : FILM, SOLUBLE

SUCRALOSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : FILM, SOLUBLE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 56038132

UNII : 96K6UQ3ZD4

Potency Amount : 5.5

Potency Unit : MG

blank

05

Dosage Form : GRANULE

SUCRALOSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : GRANULE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 56038132

UNII : 96K6UQ3ZD4

Potency Amount : 5.4

Potency Unit : MG

blank

06

Dosage Form : GRANULE, FOR ORAL SUSPENSION

SUCRALOSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : GRANULE, FOR ORAL SUSPENSION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 56038132

UNII : 96K6UQ3ZD4

Potency Amount : 2.33

Potency Unit : MG

blank

07

Dosage Form : LIQUID

SUCRALOSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : LIQUID

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 56038132

UNII : 96K6UQ3ZD4

Potency Amount : 1

Potency Unit : MG/1ML

blank

08

Dosage Form : POWDER, FOR ORAL SOLUTION

SUCRALOSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : POWDER, FOR ORAL SOLUTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 56038132

UNII : 96K6UQ3ZD4

Potency Amount : 1210

Potency Unit : MG

blank

09

Dosage Form : POWDER, FOR ORAL SUSPENSION

SUCRALOSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : POWDER, FOR ORAL SUSPENSION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 56038132

UNII : 96K6UQ3ZD4

Potency Amount : 90

Potency Unit : MG/1PKT

blank

10

Dosage Form : POWDER, FOR SOLUTION

SUCRALOSE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : POWDER, FOR SOLUTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 56038132

UNII : 96K6UQ3ZD4

Potency Amount : 34.25

Potency Unit : MG

blank
click full view

EXCIPIENTS BY APPLICATIONS

Click here to find the perfect excipient manufacturers by their capabilities

Taste Masking

read-more
read-more

MARKET PLACE

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty